Showing results (131-140 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|November 4, 2006
Simple graphical methods of displaying multiple clinical resultsL Squassante, C N Robinson, R L PalmerPharmaceutical Statistics|May 4, 2007
A brief review of Phase 1 and Clinical Pharmacology statistics in clinical drug developmentScott D Patterson, Byron JonesPharmaceutical Statistics|March 6, 2007
Modeling attainment of steady state of drug concentration in plasma by means of a Bayesian approach using MCMC methodsPaul Jordan, Hadassa Brunschwig, Eric LuedinPharmaceutical Statistics|March 14, 2007
Biomarkers in drug development: friend or foe? A personal reflection gained working within oncologyKevin J CarrollPharmaceutical Statistics|June 8, 2007
Estimation of the marginal survival time in the presence of dependent competing risks using inverse probability of censoring weighted (IPCW) methodsYutaka Matsuyama, Takuhiro YamaguchiPharmaceutical Statistics|September 23, 2009
The application of bespoke spending functions in group-sequential designs and the effect of delayed treatment switching in survival trialsAndrew StonePharmaceutical Statistics|June 24, 2010
A method for obtaining randomized block designs in preclinical studies with multiple quantitative blocking variablesStephen J IturriaPharmaceutical Statistics|September 21, 2011
Determining the non-inferiority margin for patient reported outcomesChristoph Gerlinger, Thomas SchmelterPharmaceutical Statistics|February 17, 2012
A note on effective sample size for constructing confidence intervals for the difference of two proportionsGuanghan F LiuPharmaceutical Statistics|December 1, 2011
A review of risk measures in pharmacoepidemiology with tips for statisticians in the pharmaceutical industryGeorge Quartey, Jixian Wang, Joseph KimPageof 119